Adcendo ApS Announces License Agreement with Duality Biologics on Next-generation ADC Platform Read more
Mission Bio and Abiosciences Partner to Co-develop Bioinformatics for Clinical Research Applications in China Read more
TFF Pharmaceuticals Receives Approval from Health Canada to Enter Human Clinical Trials for Inhaled Formulation of Niclosamide to Treat COVID-19 Read more
Brii Biosciences Announces Positive Data from the Phase 3 ACTIV-2 Trial Evaluating Combination BRII-196 and BRII-198 in Non-Hospitalized COVID-19 Patients Read more
Bird Rock Bio Files IND Application for Phase 2 Study of Nimacimab for Treatment of Renal Diseases Read more
Neuroptika Announces Enrollment Of First Patient In Phase 2 Clinical Trial For Dry Eye Disease Read more
Farxiga met primary endpoint in landmark Phase III DAPA-HF trial for the treatment of patients with heart failure Read more
Sanofi : Dupixent (dupilumab) showed positive topline results in Phase 3 trial of children aged 6 to 11 years with severe atopic dermatitis Read more
Novartis Kisqali significantly prolongs life in women with HR+/HER2- advanced breast cancer now in two distinct Phase III trials Read more